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Letters to the
Editor
Evaluation of surgical trauma and
cardiopulmonary bypass as factors
in inflammatory status after cardiac
surgery
To the Editor:
I read with interest Prondzinsky and col-
leagues’ article1 “Surgical Trauma Affects
the Proinflammatory Status After Cardiac
Surgery to a Higher Degree Than Cardiopul-
monary Bypass.” Because there was no con-
trol group, cardiopulmonary bypass was con-
sidered as the sole factor in development of
generalized inflammatory response after
open procedures. In the past decade, coronary
revascularization without cardiopulmonary
bypass has become an alternative to the con-
ventional on-pump technique. Patients oper-
ated on with this technique thus could repre-
sent a control group. Several studies have
shown no difference between on-pump and
beating-heart surgery with respect to oxygen
metabolism after surgery, pulmonary dys-
function, and other aspects.2,3,4 Different fac-
tors may play a role in development of post-
operative inflammatory response, including
surgical trauma itself, heparin use, anesthetic
challenges, use of suction devices, and peri-
operative stress. Prondzinsky and colleagues1
in their study supported the opinion that the
cardiopulmonary bypass is not the sole factor
in generation of postoperative inflammatory
response. More large, randomized trials
studying different inflammatory pathways
are still required to confirm this finding.
Elsayed M. Elmistekawy, MD
Cardiac Services Department
North West Armed Forces Hospital
Tabuk, Saudi Arabia
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Reply to the Editor:
Thank you for the invitation to respond to
Elsayed M. Elmistekawy=s letter to the ed-
itor. The aim of our study was to show the
effect of trauma and cardiac bypass on the
systemic inflammatory response during
coronary revascularization with and with-
out cardiopulmonary bypass (CPB) to de-
termine the contribution of CPB to the total
amount of interleukin (IL) 6 release during
the perioperative period.
Elmistekawy states that coronary revas-
cularization without CPB should have been
investigated as a control group. In our
study we used patients without surgical
trauma as a positive control group, compar-
ing them with patients with surgical
trauma. The additional IL-6 release during
the perioperative period was used to define
the contribution of CPB by “subtraction” of
the trauma-induced inflammatory response.
We agree an additional “negative control
group” without CPB would have been
helpful to determine the extent of the con-
tribution. Nevertheless, despite the lack of
a negative control group, the published
data, in our opinion, clearly demonstrate
that both aspects, trauma with all related
factors and the CPB, contribute to the peri-
operative inflammatory response. These
conclusions are in agreement with the find-
ings of Hazama and colleagues,1 who dem-
onstrated that off-pump coronary artery re-
vascularization leads to a significant
decreased inflammatory response.
Considering these data by Hazama and
colleagues and other published data, it is
questionable that larger randomized trials
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